Srividya Kidambi, MD
Endocrinology, Diabetes & Metabolism · Milwaukee, WINPI 1376614446
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $56 of the $88 with a category attached, or 63.5%. Every reported general payment came from a single manufacturer, Novo Nordisk. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in WI, where the typical reported total is $280.
Across 4 payments — averaging $22.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$88
Across 24 payments — averaging $2396.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$40K
- Novo Nordisk AS$17K
- Amgen$646
- Amryt Pharma Holdings Ltd$96
- Chiesi USA, Inc.$63
What the payments were for
- Food & beverage$5664%
- Education$3236%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 4 | $88 |
How this compares
$88 in reported general payments places this provider in the 25th percentile of 127 endocrinology, diabetes & metabolism providers in Wisconsin.
See all endocrinology, diabetes & metabolism providers in Wisconsin →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 91 | $155,011 |
| MounjaroTirzepatide | 56 | $71,510 |
| TrulicityDulaglutide | 39 | $58,638 |
| JardianceEmpagliflozin | 28 | $36,443 |
| TymlosAbaloparatide | 13 | $34,769 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 14 | $10,905 |
| Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm | 16 | $4,897 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 12 | $4,536 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $4,462 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 24 | $3,981 |
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 14 | $1,980 |
| Metformin Hcl ErMetformin Hcl | 118 | $1,005 |
| Levothyroxine Sodium | 48 | $546 |
| Hydrocortisone | 16 | $429 |
| Metformin Hcl | 25 | $191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $88 | $155,01191 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 127 endocrinology, diabetes & metabolism providers in Wisconsin.
Other endocrinology, diabetes & metabolism in Milwaukee
- Denise Teves QuallerMilwaukee$56K
- Elaine DrobnyMilwaukee$29K
- Adriana IoachimescuMilwaukee$26K
- Catherine ZhangMilwaukee$16K
- Timur GusovMilwaukee$5K
- Antoni GofronMilwaukee$5K
- Anil ChandelMilwaukee$3K
- Michael VossMilwaukee$2K
- Olena KlindukhovaMilwaukee$1K
- Usonwanne IbekweMilwaukee$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.